Diabetic retinopathy;Retinopatia diabetica

Nutricion Hospitalaria

Volumn 28, Issue SUPPL2, 2013, Pages 53-56

  Moreno, A ^a   Lozano, M ^a   Salinas, P ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Diabetic retinopathy; Metabolic surgery; VEGF

Indexed keywords

ARTICLE; DIABETIC RETINOPATHY; HUMAN;

DIABETIC RETINOPATHY; HUMANS;

EID: 84876432208     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2013.28.sup2.6568     Document Type: Article

References (15)

1. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity an diabetes in the United States. JAMA 2001; 286: 1195-2000.
2. Klein R, Klein BEK, Moss SE et al. The Wisconsin epidemiology study of diabetic retinopathy II. Prevalence and risk of diabetes retinopathy when age at diagnosis less than 30 years. Arch Opthalmol 1984; 102: 520-526.
3. Klein R, Klein BEK, Moss SE et al. The Wisconsin epidemiology study of diabetic retinopathy III. Prevalence and risk of diabetes retinopathy when age at diagnosis less than 30 years. Arch Opthalmol 1984; 102: 527-532.
4. DCCT(Diabetes Control and Complications Trial Research Group. The relationship of glycaemic exposure(HbAlc) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995; 44: 968-983.
5. Klein R, Klein BEK, Lee KE et al. The incidence of hypertension in insulin dependent diabetes. Arch Internal Medicine 1996; 156: 622-677.
6. DCCT(Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 2000; 23: 1084-1091.
7. Fong DS, Aiello L, Gardner TW et al. Rethinopaty in diabetes (for the American Diabetes Association). Diabetes Care 2004; 27: s84-s87.
8. Lyons TJ, Jenfins AJ, Zheng D et al. Diabetic Retinopathy and serum lipoprotein subclasses in the DCCT/EDIC COHORT. Invest Ophthalmol Vis Sci 2004; 45: 910-918.
9. Davis MD, Fisher MR, Gangnon RE et al. Risk factors for highrisk proliferative diabetic retinopathy and several visula loss: Early treatment retinopathy study Report 18. Inves Ophthalmol Vis Sci 1998; 39: 233-252.
10. Wong TY, Shanka A, Klein R, Klein BE. Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with tipe1 diabetes. Diabetes 2004; 53: 179-184
11. Aiello LP, Bursell S, Clermont A et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective betaisoform-selective inhibitor. Diabetes 1997; 46: 1473-1480.
12. Aiello LM. Perspectives on Diabetic Retinopathy. Am J Ophthalmol 2003; 136; 122-135.
13. Mesa-Gutiérrez JC, Porta-Monnet J, Cabiró-Badimon I, Amias-Lamana V, Rouras-Lopez A. Protocolos de tratamiento de la maculopatia diabética. Annals d'Oftalmologia 2010; 18: 86-91.
14. Yang CM. Treatment for severe diabetic macular edema. Am Journal Opthalmol 2000; 129: 487-494.
15. Nguyen QD, Shah SM, Khwaja AA. Two-year outcomes of the ranibizumab for edema of the macula in diabetes study (Read 2). Ophtalmology 2010; 117: 2146-2151.